Key stats
About CHINA SOUTHERN FUN
Home page
Inception date
Mar 12, 2021
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Primary advisor
China Southern Asset Management Co., Ltd.
ISIN
CNE100004GW8
Closely track underlying index,Tightly track the target and minimize the deviation
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.85%
Health Technology99.24%
Commercial Services0.60%
Bonds, Cash & Other0.15%
Cash0.15%
Stock breakdown by region
Asia97.83%
Europe2.17%
North America0.00%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
159858 invests in stocks. The fund's major sectors are Health Technology, with 99.24% stocks, and Commercial Services, with 0.60% of the basket. The assets are mostly located in the Asia region.
159858 top holdings are WuXi AppTec Co., Ltd. Class A and Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A, occupying 10.09% and 10.05% of the portfolio correspondingly.
159858 assets under management is 204.98 M CNY. It's risen 4.77% over the last month.
159858 fund flows account for −30.73 M CNY (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, 159858 doesn't pay dividends to its holders.
159858 shares are issued by China Southern Asset Management Co., Ltd. under the brand China Southern. The ETF was launched on Mar 12, 2021, and its management style is Passive.
159858 expense ratio is 0.20% meaning you'd have to pay 0.20% of your investment to help manage the fund.
159858 follows the CSI Innovative Pharmaceutical Industrial Index - CNY - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
159858 invests in stocks.
159858 price has risen by 6.68% over the last month, and its yearly performance shows a 41.92% increase. See more dynamics on 159858 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 10.71% over the last month, showed a 22.57% increase in three-month performance and has increased by 42.34% in a year.
NAV returns, another gauge of an ETF dynamics, have risen by 10.71% over the last month, showed a 22.57% increase in three-month performance and has increased by 42.34% in a year.
159858 trades at a premium (0.07%) meaning the ETF is trading at a higher price than the calculated NAV.